1 recruiting. .
Follow Xueqin Yang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC RecistTM criteria - Evaluation, NSCLC | Recruiting | Xueqin Yang | 44 | 2023-11-13 | 2023-11-21 |
Response Evaluation Criteria in Solid Tumors (1)
China (1)